We are live on
!
Find out more
GCM
Ghisallo Capital Management Portfolio holdings
AUM
$3.63B
1-Year Est. Return
30.51%
This Fund
S&P 500
This Quarter
Est. Return
-2.07%
1 Year Est. Return
+30.51%
3 Year Est. Return
+102.79%
5 Year Est. Return
+106.47%
10 Year Est. Return
–
AUM
$2.02B
AUM Growth
-$610M
(-23%)
Cap. Flow
-$464M
Cap. Flow
% of AUM
-22.96%
Top 10 Holdings %
Top 10 Hldgs %
15.91%
Holding
593
New
137
Increased
10
Reduced
43
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$72M |
| 2 |
Blackstone
BX
|
+$33.3M |
| 3 |
Clover Health Investments
CLOV
|
+$32.5M |
| 4 |
Albertsons Companies
ACI
|
+$31.7M |
| 5 |
Weibo
WB
|
+$28.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$105M |
| 2 |
Clarivate
CLVT
|
+$58.9M |
| 3 |
Opendoor
OPEN
|
+$57.5M |
| 4 |
VICI Properties
VICI
|
+$56.8M |
| 5 |
EQT Corp
EQT
|
+$51.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.7% |
| 2 | Technology | 26.65% |
| 3 | Consumer Discretionary | 15.3% |
| 4 | Healthcare | 7.21% |
| 5 | Industrials | 6.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Intellia Therapeutics
NTLA
$1.68B
| – | – |
-20,000
| Closed | -$2.68M |
|
|
NUVL
502
DELISTED
Nuvalent
NUVL
| – | – |
-10,000
| Closed | -$226K |
|
|
TEAD
503
Teads Holding Co
TEAD
$64.5M
| – | – |
-250,000
| Closed | -$3.7M |
|
504
Offerpad Solutions
OPAD
$22.9M
| – | – |
-2,367
| Closed | -$3.1M |
|
|
505
Opendoor
OPEN
$3.38B
| – | – |
-2,893,333
| Closed | -$57.5M |
|
506
Ranpak Holdings
PACK
$446M
| – | – |
-20,000
| Closed | -$536K |
|
507
Phreesia
PHR
$769M
| – | – |
-20,000
| Closed | -$1.23M |
|
508
Palantir
PLTR
$421B
| – | – |
-289,830
| Closed | -$6.97M |
|
|
RBOT
509
DELISTED
Vicarious Surgical
RBOT
| – | – |
-3,333
| Closed | -$1.5M |
|
510
Rigetti Computing
RGTI
$5.89B
| – | – |
-300,000
| Closed | -$2.92M |
|
511
Rocket Lab Corp
RKLB
$50B
| – | – |
-500,000
| Closed | -$8.06M |
|
512
RLX Technology
RLX
$2.44B
| – | – |
-15,000
| Closed | -$68K |
|
513
ReNew
RNW
$2.23B
| – | – |
-700,000
| Closed | -$7.14M |
|
514
Rapid Micro Biosystems
RPID
$85.8M
| – | – |
-50,000
| Closed | -$924K |
|
515
Sera Prognostics
SERA
$78.7M
| – | – |
-10,000
| Closed | -$111K |
|
516
SES AI
SES
$196M
| – | – |
-241,652
| Closed | -$2.39M |
|
517
SmartRent
SMRT
$261M
| – | – |
-350,000
| Closed | -$4.56M |
|
|
SNCY
518
DELISTED
Sun Country Airlines
SNCY
| – | – |
-15,000
| Closed | -$503K |
|
|
SOND
519
DELISTED
Sonder
SOND
| – | – |
-10,000
| Closed | -$1.98M |
|
520
SOPHiA GENETICS
SOPH
$643M
| – | – |
-20,000
| Closed | -$351K |
|
521
ThredUp
TDUP
$424M
| – | – |
-60,000
| Closed | -$1.3M |
|
522
Treace Medical Concepts
TMCI
$304M
| – | – |
-15,000
| Closed | -$404K |
|
523
T-Mobile US
TMUS
$191B
| – | – |
-250,000
| Closed | -$31.9M |
|
524
Tenaya Therapeutics
TNYA
$165M
| – | – |
-15,000
| Closed | -$310K |
|
|
TRML
525
DELISTED
Tourmaline Bio
TRML
| – | – |
-1,500
| Closed | -$203K |
|
Similar funds
VI
ACM
SCM
OCM
SL
AA
GCM
MTIM
Ghisallo Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Ghisallo Capital Management held 593 positions worth $2.02B, down 23% from $2.63B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ghisallo Capital Management withdrew a net $464M in Q4 2021, closing 147 positions and reducing 43 holdings. Its most notable exit was Coupang, an estimated $105M position sold in full.
By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Ghisallo Capital Management opened a new position in Rivian worth $64.8M.
- Ghisallo Capital Management's largest Q4 2021 buy was Rivian: 625,000 shares worth $64.8M.
- Ghisallo Capital Management added most to Snowflake in Q4 2021, an estimated $17.4M increase.
- Ghisallo Capital Management's biggest Q4 2021 reduction was Sea Limited, cutting an estimated $50.7M.
- Ghisallo Capital Management fully exited Coupang in Q4 2021, selling an estimated $105M.
- Ghisallo Capital Management's ten largest holdings make up 16% of its $2.02B portfolio in Q4 2021.
- Ghisallo Capital Management opened 137 new positions and closed 147 in Q4 2021.
- Ghisallo Capital Management's portfolio value fell 23% quarter-over-quarter to $2.02B.
Based on Ghisallo Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.